Form 8-K - Current report:
SEC Accession No. 0001564590-20-040019
Filing Date
2020-08-13
Accepted
2020-08-13 16:10:37
Documents
3
Period of Report
2020-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K trvi-8k_20200813.htm 8-K 36312
2 EX-99.1 trvi-ex991_6.htm EX-99.1 118748
3 GRAPHIC gvfcnl3pwxbc000001.jpg GRAPHIC 2233
  Complete submission text file 0001564590-20-040019.txt   159431
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38886 | Film No.: 201099403
SIC: 2834 Pharmaceutical Preparations